Expand/collapse navigation
Home
About Us
Management
Directors
Diabetes Epidemic
Technology
Projects
Capsulin™
Combulin™
Oral GLP-1
Partnering
Contact
Home
About Us
Technology
Projects
Partnering
Contact
Capsulin™
Combulin™
Oral GLP-1
Oral GLP-1
Oral GLP-1 Analogue
Primary Indication
Treatment of Type 2 diabetes mellitus
Stage of Development
Entering Phase I/IIa
Outlicensing opportunity - providing oral formulation technology to GLP-1 analogue
Stimulates insulin formation and release when blood glucose levels are high
Reduces glucose output from the liver
Improves insulin sensitivity and the function of ß-cells
Slows emptying of stomach and reduces desire to eat